Literature DB >> 29124389

Dry-field maneuver for controlling the massive intraventricular bleeding during neuroendoscopic procedures.

Tuncer Turhan1.   

Abstract

PURPOSE: Massive hemorrhages pose a significant problem in intraventricular endoscopic surgeries. These hemorrhages have the potential to cause mortality and morbidity, particularly in excisional surgeries. Often, the bleeding can be controlled only by cauterization and liquid irrigation, due to the incongruity of the use of antihemorrhagic agents in the fluid. The final option to stop the massive bleeding is the dry-field maneuver. In this study, the effects and clinical results of the dry-field maneuver in bleeding control of a massive bleeding were investigated.
METHODS: Dry-field maneuver was retrospectively studied in a patient population that had massive bleeding during intraventricular endoscopic procedures.
RESULTS: Dry-field maneuver was used in seven patients. Four of these patients underwent some excisional surgery. The other two patients were operated for an endoscopic third ventriculostomy and one for intraventricular hemorrhage evacuation. It was observed that the hemorrhage in patients stopped rapidly after the dry-field maneuver. Moreover, there was no need for an antihemorrhagic material.
CONCLUSION: Dry-field maneuver is an option for providing hemostasis, particularly, for a massive hemorrhage. It also has the potential to be used in elective surgeries because it improves the visual quality.

Entities:  

Keywords:  Cerebrospinal fluid; Dry field; Intraventricular bleeding; Neuroendoscopy

Mesh:

Year:  2017        PMID: 29124389     DOI: 10.1007/s00381-017-3652-2

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  11 in total

1.  Neuroendoscopic surgery in empty ventricular system under continuous gas infusion experimental study of pressure changes and complications.

Authors:  Tuncer Turhan; Ömer Aydın; Yusuf Ersahin
Journal:  Childs Nerv Syst       Date:  2011-09-21       Impact factor: 1.475

2.  Basilar artery perforation as a complication of endoscopic third ventriculostomy.

Authors:  K Abtin; B G Thompson; M L Walker
Journal:  Pediatr Neurosurg       Date:  1998-01       Impact factor: 1.162

3.  Ventriculofiberscope: a new technique for endoscopic diagnosis and operation. Technical note.

Authors:  T Fukushima; B Ishijima; K Hirakawa; N Nakamura; K Sano
Journal:  J Neurosurg       Date:  1973-02       Impact factor: 5.115

Review 4.  Shunts vs endoscopic third ventriculostomy in infants: are there different types and/or rates of complications? A review.

Authors:  C Di Rocco; L Massimi; G Tamburrini
Journal:  Childs Nerv Syst       Date:  2006-10-20       Impact factor: 1.475

5.  Traumatic basilar aneurysm after endoscopic third ventriculostomy: case report.

Authors:  M R McLaughlin; J B Wahlig; A M Kaufmann; A L Albright
Journal:  Neurosurgery       Date:  1997-12       Impact factor: 4.654

6.  Tumors of the lateral and third ventricle: removal under endoscope-assisted keyhole conditions.

Authors:  Patra Charalampaki; Ronald Filippi; Stefan Welschehold; Jens Conrad; Axel Perneczky
Journal:  Neurosurgery       Date:  2005-10       Impact factor: 4.654

Review 7.  The role of endoscopic third ventriculostomy in the management of shunt malfunction.

Authors:  G Cinalli; C Salazar; C Mallucci; J Z Yada; M Zerah; C Sainte-Rose
Journal:  Neurosurgery       Date:  1998-12       Impact factor: 4.654

8.  Endoscopic biopsy of intraventricular tumors with the use of a ventriculofiberscope.

Authors:  T Fukushima
Journal:  Neurosurgery       Date:  1978 Mar-Apr       Impact factor: 4.654

Review 9.  Coagulopathy: its pathophysiology and treatment in the injured patient.

Authors:  Brandon H Tieu; John B Holcomb; Martin A Schreiber
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

10.  Complications of endoscopic third ventriculostomy.

Authors:  Henry W S Schroeder; Wulf-Rüdiger Niendorf; Michael R Gaab
Journal:  J Neurosurg       Date:  2002-06       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.